HighMark Wealth Management’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-750
Closed -$11.5K 562
2025
Q4
$11.5K Hold
750
﹤0.01% 298
2025
Q3
$7.45K Hold
750
﹤0.01% 341
2025
Q2
$7.44K Hold
750
﹤0.01% 349
2025
Q1
$9.73K Hold
750
0.01% 292
2024
Q4
$9.58K Hold
750
0.01% 296
2024
Q3
$8.36K Hold
750
﹤0.01% 323
2024
Q2
$8.42K Hold
750
0.01% 311
2024
Q1
$9.31K Hold
750
0.01% 291
2023
Q4
$10.5K Hold
750
0.01% 257
2023
Q3
$11.1K Hold
750
0.01% 246
2023
Q2
$9.69K Hold
750
0.01% 262
2023
Q1
$7.36K Hold
750
0.01% 341
2022
Q4
$7.98K Hold
750
0.01% 284
2022
Q3
$8K Hold
750
0.01% 268
2022
Q2
$9K Hold
750
0.01% 259
2022
Q1
$8K Hold
750
0.01% 294
2021
Q4
$11K Hold
750
0.01% 245
2021
Q3
$14K Hold
750
0.01% 217
2021
Q2
$7K Hold
750
0.01% 301
2021
Q1
$7K Hold
750
0.01% 290
2020
Q4
$3K Hold
750
﹤0.01% 379
2020
Q3
$3K Hold
750
﹤0.01% 362
2020
Q2
$7K Hold
750
0.01% 263
2020
Q1
$2K Hold
750
﹤0.01% 294
2019
Q4
$4K Buy
+750
New +$4.01K ﹤0.01% 295

Other funds holding DVAX

HighMark Wealth Management's DVAX Position: Q1 2026 in Review

HighMark Wealth Management sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 750 shares — an estimated $11.5K sold.

HighMark Wealth Management first reported a position in DVAX in Q4 2019 and held it in 25 quarters. The position peaked at $14K in Q3 2021. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • HighMark Wealth Management reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • HighMark Wealth Management sold 750 Dynavax Technologies shares in Q1 2026, an estimated $11.5K.
  • HighMark Wealth Management first reported a position in Dynavax Technologies in Q4 2019 and held it in 25 quarters.
  • HighMark Wealth Management's Dynavax Technologies position peaked at $14K in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on HighMark Wealth Management's 13F filing for Q1 2026, filed 6 May 2026.